BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 21923247)

  • 21. [Transsphenoidal surgery of secretory and invasive pituitary adenomas (somatotropinoma or corticotropinoma)--own experiences].
    Zieliński G; Podgórski JK; Koziarski A; Potakiewicz Z; Warczyńska A; Zgliczyński W; Makowska A
    Przegl Lek; 2004; 61(9):928-34. PubMed ID: 15803901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endoscopic transsphenoidal pituitary surgery: a good and safe primary treatment option for Cushing's disease, even in case of macroadenomas or invasive adenomas.
    Wagenmakers MA; Boogaarts HD; Roerink SH; Timmers HJ; Stikkelbroeck NM; Smit JW; van Lindert EJ; Netea-Maier RT; Grotenhuis JA; Hermus AR
    Eur J Endocrinol; 2013 Sep; 169(3):329-37. PubMed ID: 23786985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endoscopic Endonasal Surgery for Tumors of the Cavernous Sinus: A Series of 234 Patients.
    Koutourousiou M; Vaz Guimaraes Filho F; Fernandez-Miranda JC; Wang EW; Stefko ST; Snyderman CH; Gardner PA
    World Neurosurg; 2017 Jul; 103():713-732. PubMed ID: 28450229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of transsphenoidal surgery in achieving biochemical cure of growth hormone-secreting pituitary adenomas among patients with cavernous sinus invasion: a systematic review and meta-analysis.
    Briceno V; Zaidi HA; Doucette JA; Onomichi KB; Alreshidi A; Mekary RA; Smith TR
    Neurol Res; 2017 May; 39(5):387-398. PubMed ID: 28301972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term results of stereotactic gamma knife radiosurgery for pituitary adenomas. Specific strategies for different types of adenoma.
    Kobayashi T
    Prog Neurol Surg; 2009; 22():77-95. PubMed ID: 18948721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of Cushing's disease: outcome in patients with microadenoma detected on pituitary magnetic resonance imaging.
    Prevedello DM; Pouratian N; Sherman J; Jane JA; Vance ML; Lopes MB; Laws ER
    J Neurosurg; 2008 Oct; 109(4):751-9. PubMed ID: 18826366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification.
    Micko AS; Wöhrer A; Wolfsberger S; Knosp E
    J Neurosurg; 2015 Apr; 122(4):803-11. PubMed ID: 25658782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Parameters of Silent Corticotroph Adenomas With Positive and Negative Adrenocorticotropic Hormone Immunostaining: A Large Retrospective Single-Center Study of 105 Cases.
    Zhang K; Shou X; Chen H; Qiao N; He W; Chen Z; Shen M; Li S; Zhao Y; Zhang Z; Li Y; Ye H; Wang Y
    Front Endocrinol (Lausanne); 2020; 11():608691. PubMed ID: 33584540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical management of adrenocorticotropic hormone-secreting macroadenomas: outcome and challenges in patients with Cushing's disease or Nelson's syndrome.
    De Tommasi C; Vance ML; Okonkwo DO; Diallo A; Laws ER
    J Neurosurg; 2005 Nov; 103(5):825-30. PubMed ID: 16304985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First Report of Coexistence of Two Ectopic Pituitary Tumors: Rathke Cleft Cyst and Silent Adrenocorticotropic Hormone Adenoma.
    Pojskić M; Zbytek B; Beckford NS; Boop FA; Arnautović KI
    World Neurosurg; 2017 Aug; 104():1048.e1-1048.e7. PubMed ID: 28532906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of normal perisellar anatomy in 1.5 T T2-weighted MRI and comparison with the anatomic criteria defining cavernous sinus invasion of pituitary adenomas.
    Knappe UJ; Jaursch-Hancke C; Schönmayr R; Lörcher U
    Cent Eur Neurosurg; 2009 Aug; 70(3):130-6. PubMed ID: 19701871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Removal of the Medial Wall of the Cavernous Sinus for Functional Pituitary Adenomas: A Technical Report and Pathologic Significance.
    Nagata Y; Takeuchi K; Yamamoto T; Ishikawa T; Kawabata T; Shimoyama Y; Wakabayashi T
    World Neurosurg; 2019 Jun; 126():53-58. PubMed ID: 30849552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical importance of the basal cavernous sinuses and cavernous carotid arteries relative to the pituitary gland and macroadenomas: quantitative analysis of the complete anatomy.
    Yilmazlar S; Kocaeli H; Eyigor O; Hakyemez B; Korfali E
    Surg Neurol; 2008 Aug; 70(2):165-74; discussion 174-5. PubMed ID: 18262607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comprehensive long-term retrospective analysis of silent corticotrophic adenomas vs hormone-negative adenomas.
    Jahangiri A; Wagner JR; Pekmezci M; Hiniker A; Chang EF; Kunwar S; Blevins L; Aghi MK
    Neurosurgery; 2013 Jul; 73(1):8-17; discussion 17-8. PubMed ID: 23685641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The occurrence of dural invasion in pituitary adenomas.
    Selman WR; Laws ER; Scheithauer BW; Carpenter SM
    J Neurosurg; 1986 Mar; 64(3):402-7. PubMed ID: 3950720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective intraoperative and histologic evaluation of cavernous sinus medial wall invasion by pituitary adenomas and its implications for acromegaly remission outcomes.
    Mohyeldin A; Katznelson LJ; Hoffman AR; Asmaro K; Ahmadian SS; Eltobgy MM; Nayak JV; Patel ZM; Hwang PH; Fernandez-Miranda JC
    Sci Rep; 2022 Jun; 12(1):9919. PubMed ID: 35705579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gamma Knife surgery for adrenocorticotropic hormone-producing pituitary adenomas after bilateral adrenalectomy.
    Mauermann WJ; Sheehan JP; Chernavvsky DR; Laws ER; Steiner L; Vance ML
    J Neurosurg; 2007 Jun; 106(6):988-93. PubMed ID: 17564169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathological correlates of extrasellar growth patterns in pituitary adenomas.
    Sarkar S; Chacko AG; Chacko G
    J Clin Neurosci; 2015 Jul; 22(7):1173-7. PubMed ID: 25979255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. POSTSURGICAL RECURRENT CUSHING DISEASE: CLINICAL BENEFIT OF EARLY INTERVENTION IN PATIENTS WITH NORMAL URINARY FREE CORTISOL.
    Carroll TB; Javorsky BR; Findling JW
    Endocr Pract; 2016 Oct; 22(10):1216-1223. PubMed ID: 27409817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cushing's disease due to double pituitary ACTH-secreting adenomas: the first case report.
    Andrioli M; Pecori Giraldi F; Losa M; Terreni M; Invitti C; Cavagnini F
    Endocr J; 2010; 57(9):833-7. PubMed ID: 20595779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.